How Dangerous Is a Temporal Artery Biopsy?

A temporal artery biopsy is one of the safest surgical procedures in medicine. It is a short outpatient operation performed under local anesthesia, and serious complications are genuinely rare. The procedure exists primarily to diagnose giant cell arteritis, an inflammatory condition that can cause blindness or stroke if untreated, so the risk of skipping the biopsy typically dwarfs the risk of having one. That said, no procedure is zero-risk, and the complications that do occur, particularly nerve injury near the eyebrow, deserve a clear-eyed look.

What the Procedure Actually Involves

The superficial temporal artery runs along the side of your head, just in front of and above the ear. During a biopsy, a surgeon numbs the area with local anesthetic, makes a small incision along the hairline or just in front of it, isolates a segment of the artery, ties off both ends, and removes the segment for examination under a microscope. The incision is typically a few centimeters long, and the whole thing takes about 30 to 45 minutes. The surgical technique pays close attention to the layers of tissue and the nearby branches of the facial nerve to avoid damage during the operation.1Ophthalmic Surgery, Lasers and Imaging Retina. Temporal Artery Biopsy Technique: A Clinico-Anatomical Approach You go home the same day with a small dressing, and the incision usually heals with a faint scar that is hidden by the hairline in most people.

The Main Complications and How Common They Are

The published literature consistently describes temporal artery biopsy as a low-complication procedure.2PubMed Central. Temporal artery biopsy in giant cell arteritis: clinical perspectives and histological patterns The complications that do get reported fall into a few categories:

  • Wound infection: In one study of 75 biopsies, two patients developed postoperative infections, a rate of about 3%.3PubMed. Brow ptosis after temporal artery biopsy: incidence and associations These are typically minor skin infections treatable with antibiotics.
  • Bleeding or hematoma: Some bruising and swelling around the incision is normal. Significant bleeding is uncommon even in patients taking blood thinners, as discussed below.
  • Facial nerve injury: This is the complication that gets the most attention in the medical literature and the one most likely to concern patients. The temporal branch of the facial nerve runs close to the surgical site, and if it is stretched or nicked, you can develop weakness in the muscles that raise your eyebrow on that side.
  • Scarring: The scar is usually small and tucked near the hairline. Poor wound healing is unusual but possible, particularly in patients already on high-dose steroids for suspected giant cell arteritis.

Scalp necrosis, where the skin around the biopsy site dies, is reported almost exclusively in patients who already have severe giant cell arteritis affecting blood flow to the scalp. It is extraordinarily rare and relates more to the underlying disease than to the biopsy itself.4PubMed Central. Scalp necrosis and giant cell arteritis: case report and issues in wound management

Nerve Injury and Brow Droop

Damage to the temporal branch of the facial nerve is the complication that researchers have studied most closely, because even though it is uncommon, it can be cosmetically significant. If the nerve is injured during surgery, the frontalis muscle on that side of the forehead stops working properly. The result is a drooping eyebrow, sometimes called brow ptosis, which can make one eye look noticeably different from the other.

One study that specifically tracked this outcome found that roughly 10% of patients had some frontalis weakness six months after their biopsy. By one year, that number had dropped to about 3%, suggesting most cases recover on their own.5Nature (Eye). Temporal artery biopsy: time for a rethink on training? The cases that persist beyond a year can cause permanent asymmetry in the brow. It is worth noting that this complication is described as uncommon and sparsely reported across the broader literature, so the 10% figure from one dedicated study may overstate the typical experience across all centers.6PubMed Central. Branch facial nerve trauma after superficial temporal artery biopsy: a case report

The risk of nerve injury is closely tied to technique. Surgeons who are familiar with the anatomy of the region, particularly the varying paths the nerve can take, are better positioned to avoid it. This is one reason the procedure is typically performed by ophthalmologists, vascular surgeons, or other specialists with experience in the area rather than by generalists working from memory.

Blood Thinners and Bleeding Risk

Many patients referred for a temporal artery biopsy are older adults who take anticoagulant medications. A natural worry is whether the biopsy will cause dangerous bleeding if you stay on your blood thinners. The available evidence is reassuring. A study examining patients who continued their anticoagulation therapy before the biopsy found that they developed minimal complications related to the procedure. The researchers concluded that there may not be enough evidence to recommend routinely stopping anticoagulants beforehand.7Arthritis & Rheumatology. Is It Necessary to Hold Anticoagulation Prior to Temporal Artery Biopsy?

This matters practically because stopping blood thinners carries its own risks, including blood clots and stroke. If your surgeon tells you to keep taking your medications, that advice is backed by evidence. Of course, the decision is always individualized, so follow whatever your own care team recommends based on your specific situation and medications.

Why the Biopsy Exists in the First Place

Giant cell arteritis is an inflammatory condition affecting medium and large blood vessels, most commonly the arteries in the temples. Left untreated, it can cause sudden, permanent vision loss or stroke. Temporal artery biopsy remains the gold standard for diagnosis, with perfect specificity (meaning a positive result is definitive) and a sensitivity of about 77%, meaning it catches roughly three-quarters of true cases.8PubMed Central. Temporal artery biopsy for suspected giant cell arteritis: A mini review The false-negative rate of roughly 6 to 17% is a known limitation, particularly when the inflamed segments of the artery are patchy and the biopsy happens to sample a normal-looking stretch.9Scientific Reports. PET/MRI in large-vessel vasculitis: clinical value for diagnosis and assessment of disease activity

This context matters for the safety question because the disease being investigated is serious. A missed or delayed diagnosis of giant cell arteritis can lead to irreversible blindness within days. Weighed against that, the minor risks of a biopsy performed under local anesthesia are almost always considered acceptable by both clinicians and patients.

Getting a Good Sample Matters More Than You Might Think

One underappreciated aspect of the risk-benefit calculation is that a poorly performed biopsy can mean having to do it again. If the removed segment is too short, the pathologist may not have enough tissue to detect the characteristic inflammation, especially since giant cell arteritis can skip segments of the artery. Research confirms that longer biopsy specimens improve diagnostic accuracy. A study examining the relationship between specimen length and positive results found that a specimen of at least 15 millimeters is the appropriate target.10PubMed Central. Diagnosis of giant cell arteritis by temporal artery biopsy is associated with biopsy length A biopsy that comes back negative because it was too short does not rule out the disease, which can leave you in limbo and potentially facing a second procedure.

Similarly, in a small number of cases the disease is present in the temporal artery on one side of the head but not the other. When bilateral biopsies are performed, the two sides disagree in roughly 3% of cases.11PubMed. Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis A separate study found a similar discordance rate of about 2.7%.12Journal of Neuro-Ophthalmology. Effect of Temporal Artery Biopsy Length and Laterality on Diagnostic Yield Whether to biopsy both sides is a judgment call your doctor makes based on clinical suspicion. For someone already strongly suspected of having the disease, a bilateral biopsy slightly increases the chance of a definitive answer but doubles the (still small) surgical risk.

Does Steroid Treatment Before the Biopsy Change the Result?

Here is a scenario that comes up constantly in practice: your doctor suspects giant cell arteritis and starts you on high-dose steroids right away to protect your vision, but the biopsy cannot be scheduled for days or even weeks. Will the steroids erase the inflammatory changes the pathologist is looking for?

The answer is nuanced. Steroid treatment does gradually reduce the signs of inflammation in the artery wall, but the changes do not vanish overnight. One study found that biopsies performed after four or more weeks of steroid treatment were still positive in most patients.13PubMed Central. Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis Another analysis found that waiting more than seven days on steroids was linked to lower odds of a positive biopsy result.14PubMed. The Effect of Corticosteroids on Temporal Artery Biopsy Positivity in Giant Cell Arteritis: Timing is Everything And a classic study noted that biopsies can still show arteritis even after more than two weeks of corticosteroid use, as long as there are clinical signs of active disease.15PubMed. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis?

The practical takeaway: if you are already on steroids, the biopsy is still worth doing, especially within the first couple of weeks. Delaying the biopsy to “let the steroids clear” is the wrong instinct. If anything, sooner is better. But your doctor should never delay steroid treatment to wait for the biopsy, because losing your vision while waiting for a surgical slot would be a far worse outcome than a slightly degraded biopsy result.

Non-Invasive Alternatives on the Horizon

One reason the safety question matters is that several imaging technologies are positioning themselves as potential replacements for biopsy. If a scan could diagnose giant cell arteritis just as reliably, many patients could skip surgery altogether.

Ultrasound of the temporal artery is the most widely studied alternative. A Cochrane review comparing ultrasound directly against biopsy found that when specificity is set high (to minimize false positives), ultrasound had a sensitivity of about 50% while biopsy reached about 80%. When both were allowed to be less specific, ultrasound’s sensitivity rose to about 73% and biopsy’s to about 92%. The review rated the evidence as very low certainty, partly because biopsy has a built-in advantage in the comparison: it is already part of the diagnostic criteria for the disease.16PubMed Central. Halo sign on temporal artery ultrasound versus temporal artery biopsy for giant cell arteritis

PET/CT scanning, which images inflammation throughout the body, is emerging as a strong contender. A recent head-to-head comparison found that combined cranial and large-vessel PET/CT had a sensitivity of 89% and specificity of 98%, outperforming both biopsy (77% sensitivity) and ultrasound (55% sensitivity) in that particular study.17PubMed. Direct comparison of the diagnostic accuracy of PET/CT, cranial MRI, ultrasound and temporal artery biopsy in giant cell arteritis PET/CT also has the advantage of detecting inflammation in vessels beyond the temporal arteries, which matters because giant cell arteritis can affect the aorta and its branches.

These imaging approaches are not yet standard in most healthcare systems. Ultrasound is operator-dependent and requires specialized training, while PET/CT is expensive and not available everywhere. For now, biopsy remains the most widely used confirmatory test, though the trend in guidelines is moving toward imaging-first approaches in centers where the expertise exists. From a cost standpoint, one analysis found that using ultrasound as a first-line diagnostic tool could cut per-patient diagnostic costs by roughly 60% compared to the traditional biopsy pathway.18Reumatología Clínica. Cost-effectiveness analysis of the diagnosis of temporal arteritis

Who Performs the Biopsy and Whether It Matters

Temporal artery biopsies are performed by a surprisingly wide range of specialists, and which type of surgeon does yours depends largely on where you live. A large analysis across a multi-state healthcare network found that general surgeons performed the majority of biopsies in some regions, while vascular surgeons dominated in others. The rate of positive diagnoses varied by specialty, with vascular surgeons showing the highest positivity rate at about 33%.19PubMed. Analysis of Temporal Artery Biopsy by Provider Across a Large Multi-State Health Care Network That difference likely reflects referral patterns and patient selection rather than surgical skill: a vascular surgeon may be getting referrals from rheumatologists with stronger clinical suspicion, while general surgeons may see a broader mix of cases.

The referring physician also plays a role. Patients sent for biopsy by rheumatologists and emergency department providers had the highest proportion of positive results (about a third), while those referred by primary care physicians had the lowest (about a fifth), though these differences did not reach statistical significance.20Journal of Vascular Surgery. The utility of the bilateral temporal artery biopsy for diagnosis of giant cell arteritis This pattern makes intuitive sense: specialists who see the disease regularly are probably better at selecting patients who truly need the biopsy, which means fewer unnecessary procedures and a higher hit rate in the pathology lab.

For you as a patient, the practical implication is straightforward. The procedure itself is technically simple for an experienced surgeon, regardless of their specialty label. If you have the option, a surgeon who performs the procedure regularly is preferable to one who does it once a year, because familiarity with the anatomy reduces the already-small risk of nerve injury. But this is not a procedure where you need to fly to a specialty center. Any competent surgical team at a community hospital can handle it safely.